Patents Assigned to Complement Therapeutics Limited
  • C3b binding polypeptide
    Patent number: 12544423
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed arc uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: October 20, 2022
    Date of Patent: February 10, 2026
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin
  • C3B binding polypeptide
    Patent number: 12383600
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: August 12, 2025
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin
  • C3B binding polypeptide
    Patent number: 11524050
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: December 13, 2022
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin